相关实验视频
Updated: Jun 18, 2025

08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
6.9K
在固体器官恶性瘤中使用预测生物标志物的个性化治疗:一篇评论
Haoming Tang1, Yi Xin Li1, Jun Jie Lian1
1Duke-NUS Medical School, Singapore.
Tumori
|August 2, 2024
概括
预测生物标志物对于个性化癌症治疗至关重要,改善了诊断,治疗选择和对固体器官恶性瘤的监测. 它们的应用引导了有效的管理,并提高了各种癌症患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 生物标志物研究 生物标志物研究
- 个性化医疗是个性化的医疗.
背景情况:
- 生物标志物在诊断和预测固体器官癌症的结果方面变得越来越重要.
- 预测性生物标志物指导个性化治疗策略,影响从发病到长期调整的癌症管理.
研究的目的:
- 审查预测生物标志物在治疗固体器官恶性瘤中的应用.
- 使用预测生物标志物分析个性化癌症治疗的目标,类型和临床疗效.
主要方法:
- 文献综述侧重于固体器官癌症中的预测生物标志物.
- 对常见癌症和高死亡率癌症的生物标志物引导治疗策略的分析.
- 在临床环境中预测生物标志物的相对疗效的评估.
主要成果:
- 预测性生物标志物显著影响诊断,治疗开始,以及对治疗疗效和副作用的监测.
- 使用预测生物标志物的个性化治疗方法在各种固体器官恶性瘤中是有效的.
- 该审查涵盖结肠直肠,乳腺,肺,前列腺,胰腺,肝脏,脏和中枢神经系统癌症.
结论:
- 预测性生物标志物对于推进个性化瘤学和优化固体器官恶性瘤治疗至关重要.
- 预测生物标志物的整合提高了临床实践中的治疗疗效和患者管理.
- 对生物标志物驱动疗法的进一步研究有望改善各种癌症类型的治疗结果.
更多相关视频
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
16.6K
08:52Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
4.0K
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K